- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Unresectable Triple-Negative Breast Carcinoma
Total 3105 results
-
Effector TherapeuticsTerminatedHepatocellular Carcinoma | Triple Negative Breast CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMetastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
Massachusetts General HospitalGilead SciencesRecruitingTriple Negative Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast CancerUnited States
-
PfizerTerminatedNon-Small Cell Lung Cancer | Triple-negative Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Curis, Inc.CompletedHigh-grade Serous Ovarian Cancer | Solid Tumors | Triple-Negative Breast Cancer | NUT Midline CarcinomaUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced, Androgen Receptor Positive Triple Negative Breast CancerUnited States, Spain, Belgium, Canada, Ireland, United Kingdom, Italy
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)SuspendedMetastatic Triple-Negative Breast Carcinoma | Metastatic HER2-Negative Breast CarcinomaUnited States
-
OncoTherapy Science, Inc.RecruitingRelapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Triple-Negative Breast Carcinoma | HER2-Negative Breast Carcinoma | Bilateral Breast Carcinoma | Localized Breast CarcinomaUnited States
-
National Cancer Institute (NCI)WithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Ovarian Serous Adenocarcinoma | Primary Peritoneal... and other conditions
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); American College of Radiology Imaging NetworkActive, not recruitingStage II Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States
-
Emory UniversityNational Cancer Institute (NCI)Not yet recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Gilead SciencesRecruitingBreast Cancer | Triple Negative Breast Cancer | PD-L1 NegativeUnited States
-
Gilead SciencesRecruitingStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast CancerJapan
-
Pennington Biomedical Research CenterRecruitingBreast NeoplasmsUnited States
-
Yale UniversityCompletedBreast NeoplasmsUnited States
-
University of WashingtonAbbVieNo longer availableTriple-Negative Breast Cancer | Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic MutationUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompletedBreast Cancer | Triple Negative Breast Cancer | Hormone Receptor Negative NeoplasmBelgium
-
Merck Sharp & Dohme LLCTerminatedNon-small Cell Lung Cancer (NSCLC) | Triple Negative Breast Cancer (TNBC) | NUT Midline Carcinoma (NMC) | Castration-resistant Prostate Cancer (CRPC)
-
Providence Health & ServicesInhibrx, Inc.Not yet recruitingTriple Negative Breast CancerUnited States
-
University of ChicagoNot yet recruitingTriple Negative Breast Cancer
-
Assiut UniversityNot yet recruiting
-
Institut CurieRoche Pharma AG; National Research Agency, FranceNot yet recruitingTriple Negative Breast CancerFrance
-
Institut CurieHoffmann-La RocheRecruitingTriple Negative Breast CancerFrance
-
AstraZenecaSWOG Clinical Trials Partnerships; Daiichi SankyoRecruitingBreast CancerUnited States, China, Denmark, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Belgium, Spain, Japan, France, Taiwan, Greece, Brazil, Sweden, Puerto Rico
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingTriple Negative Breast CancerChina
-
wang shusenRecruiting
-
Cantargia ABSpanish Breast Cancer Research GroupRecruitingTriple Negative Breast CancerSpain
-
Jewish General HospitalExactis InnovationRecruiting
-
Massachusetts General HospitalUniversity of Pennsylvania; Duke University; Sibley Memorial HospitalRecruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingTriple Negative Breast CancerChina
-
Fudan UniversityRecruitingTriple Negative Breast CancerChina
-
Peking Union Medical College HospitalRecruitingTriple Negative Breast CancerChina
-
Shengjing HospitalRecruiting
-
Shengjing HospitalThe People's Hospital of Liaoning Province; Liaoning Tumor Hospital & InstituteRecruiting
-
Eileen ConnollyMerck Sharp & Dohme LLCRecruitingTriple Negative Breast CancerUnited States
-
BioLite, Inc.Not yet recruiting
-
Yonsei UniversityRecruitingBreast CancerKorea, Republic of
-
Henan Cancer HospitalCompletedTriple Negative Breast CancerChina
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
University of Illinois at ChicagoActive, not recruitingTriple Negative Breast CancerUnited States
-
amy tierstenNovartisActive, not recruiting
-
Fundacion OncosurPfizer; Apices Soluciones S.L.; Pierre Fabre Ibérica, S.A.CompletedTriple Negative Breast CancerSpain
-
National Cancer Center, KoreaActive, not recruitingTriple Negative Breast CancerKorea, Republic of
-
ImmunityBio, Inc.Active, not recruiting
-
Novartis PharmaceuticalsWithdrawn
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedTriple Negative Breast CancerUnited States